ASTMH nominated Professor Rose McGready, SMRU Deputy Director, as an Honorary International Fellow. Rose received the prestigious award in recognition of outstanding accomplishment by an “individual not an American citizen who has made eminent contributions to some phase of tropical medicine and hygiene”.
The Big Data Institute Building has won a RIBA South Award 2018. RIBA, the Royal Institute of British Architects, sleected the BDIB in its annual review of 'outstanding work ... recognising the best architecture, architects, research and students'. The BDIB was honoured amongst a number of other buildings, including the Sultan Nazrin Shah Centre at Worcester College.
Business Secretary Greg Clark has today launched the £103m Rosalind Franklin Institute (RFI), a national centre of excellence that will harness disruptive technologies such as AI and robotics to improve dramatically our understanding of biology.
Oxford University broke into the top five by leapfrogging Cambridge, which fell back into sixth place. Imperial College London remained at seventh overall. University College London remained in the top 10 but was overtaken by the Swiss Federal Institute of Technology and the University of Chicago.
Primaquine can be used to prevent the transmission of falciparum malaria from human to mosquito. Bob Taylor and colleagues at the Mahidol Oxford Research Unit (MORU) developped an age-based regimen for single low-dose primaquine to block the transmission of malaria in sub-Saharan Africa.
China Vice Premier Madam Sun Chunlan and Minster of National Health Commission Ma Xiaowei visited CAMS Oxford Centre for Translational Immunology Beijing branch on 14th May 2018, accompanied by Professor Xuetao Cao and Professor Wang Chen (President of CAMS).
This recent FORMA/Oxford collaboration brings together Oxford’s expertise in disease molecular pathology and Ubiquitin biology, (including through the Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI), the Target Discovery Institute (TDI) and the Oxford Parkinson’s Disease Centre (OPDC)), and FORMA’s deep expertise in small molecule drug design and development
Science blog by Dr Marco Haenssgen who discusses the application of management thinking to solving the growing global problem of antimicrobial resistance.
If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.